期刊簡介 | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Telemedicine and e-Health According to the latest JCR data, this journal is indexed in the JCR. A previous title of this journal is TELEMED J E-HEALTH) LetPub Score 5.2
50 ratings
Rate
Reputation 6.4 Influence 3.5 Speed 9.1 | ||||||||||||||||||||
期刊簡稱 | TELEMED E-HEALTH | ||||||||||||||||||||
ISSN | 1530-5627 | ||||||||||||||||||||
E-ISSN | 1556-3669 | ||||||||||||||||||||
h-index | N.A. | ||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||
自引率 (2023-2024) | 10.70%自引率趨勢 | ||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||
官方網站 | http://www.liebertpub.com/overview/telemedicine-and-e-health/54/ | ||||||||||||||||||||
在線稿件提交 | http://mc.manuscriptcentral.com/telemedicine | ||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||
出版商 | Mary Ann Liebert Inc. | ||||||||||||||||||||
主題領域 | HEALTH CARE SCIENCES & SERVICES | ||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||
發行頻率 | |||||||||||||||||||||
創刊年 | 0 | ||||||||||||||||||||
每年文章數 | 210每年文章數趨勢 | ||||||||||||||||||||
黃金OA百分比 | 7.25% | ||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1530-5627%5BISSN%5D | ||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: | ||||||||||||||||||||
競爭力 * | 來自作者的數據: | ||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Telemedicine and e-Health] 的評論 | 撰寫評論 |
作者: 坠星小瑜 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-07-06 18:27:18 評論於 Do you always charge a review fee whether or not you accept it?(0) 讚! | 坠星小瑜 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 11:48:17 評論於 Length control in 10-12 words, usually not exceed 16 words; Tense is present simple; Usually consists of noun phrases or gerunds; Not fully capitalized, only first letters of real words are in upper case(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:27:12 評論於 The Importance of Time Management in Daily Life(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-27 17:20:12 評論於 How to Write a Better Article Title?(0) 讚! | 深渊兴业 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 20:29:36 評論於 What should be paid attention to when choosing a title for an article?(0) 讚! | Oswald Edie |
作者: 思凡小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-05-17 17:55:01 評論於 Where can I pay the review fee? I have been unable to find the link to pay the review fee(0) 讚! | 思凡小可爱 |
作者: 京城书錦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-07-27 19:18:56 評論於 Acceptance rate: 25.0 | Review fee: 49.0 Emphasized research direction: Remote medical care; Sharing of research experience in technical methods: Just submitted, with over 300 numbers, which means there are over 300 manuscripts ahead, still 5 months left this year, estimated to have about 500 manuscripts in a year, this journal only publishes less than 70 papers a year, who said the acceptance rate is high(0) 讚! | 京城书錦 |
作者: 卧龙雨莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-01-05 15:31:24 評論於 Communication goppy 2019-10-17 Posted: Can I consult the great gods, after receiving the proof, is it only sent to communication, or all authors? Is there any prompt in the submission system?(0) 讚! | 卧龙雨莲 |
作者: 玉翠来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-10-17 23:46:17 評論於 Question for senior editor: After acceptance, will the proof be sent only to the corresponding author, or to all authors? Is there any indication of this in the submission system?(0) 讚! | 玉翠来了 |
作者: 苍风静涵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-09-03 16:27:38 評論於 Review speed: 3.0 Experience sharing: Overall, it is a good journal, and the impact factor rises slightly each year. It is worth considering submitting to SCI for the first time(0) 讚! | 苍风静涵 |
作者: YARY 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2018-09-03 10:41:07 評論於 Overall, it's a good journal, and the IF has been rising in recent years. If this is your first time to submit to an SCI journal, this is worth considering. (1) 讚! | YARY |
作者: 卧龙雨莲 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2018-04-13 22:30:21 評論於 Review speed: 2.0 | Submission hit rate: 50.0 Experience sharing: I have submitted 2 articles. The first one was rejected directly. The second one required minor revisions. After the revisions, it was quickly accepted. However, it took a while for it to be published after acceptance(0) 讚! | 卧龙雨莲 |
作者: 德温贝儿 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-10-19 21:36:05 評論於 The review period is very fast, but there is a review fee of $49 in the recent period(0) 讚! | 德温贝儿 |
作者: 长拳灵槐 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-08-19 11:56:24 評論於 Review Speed: 2.0 | Submission Acceptance Rate: 75.0Experience Sharing: The quality is average, but it is indexed in SCI and SSCI, and the speed is relatively fast(0) 讚! | 长拳灵槐 |
作者: 易梦小可爱 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2012-08-03 12:44:32 評論於 A moderately good journal(0) 讚! | 易梦小可爱 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us